| Annotation aspect | Summary statement | Key evidence/citations |
|---|---|---|
| Identity / synonyms | Target verified as **Danio rerio coq8a** ortholog of mammalian **COQ8A/ADCK3/CABC1**; literature distinguishes it from paralog **COQ8B/ADCK4**. The zebrafish-specific primary literature is limited, so functional annotation relies mainly on conserved ortholog evidence plus zebrafish CoQ-pathway studies. | (pqac-00000003, pqac-00000005, pqac-00000013) |
| Protein family / domains | COQ8A belongs to the **UbiB/ADCK atypical protein kinase-like family**, a protein kinase superfamily branch with an atypical kinase-like fold rather than a conventional protein kinase mechanism. This aligns with UniProt’s ABC1/ADCK family assignment. | (pqac-00000003, pqac-00000005, pqac-00000016) |
| Molecular function | Best current model: COQ8A is a **mitochondrial ATPase/kinase-like regulator** that promotes CoQ biosynthesis, likely by supporting access to or handling hydrophobic CoQ intermediates and stabilizing the biosynthetic machinery rather than by acting as a classic protein-substrate kinase. | (pqac-00000001, pqac-00000003, pqac-00000005, pqac-00000016) |
| Catalytic activity | No definitive canonical protein-kinase substrate reaction is established. Instead, **ATPase activity is required for CoQ production**; ATPase activity can be enhanced by cardiolipin-rich membranes and phenolic CoQ-like compounds. Thus, UniProt’s EC 2.7.-.- should be interpreted cautiously as kinase-like, not a well-defined phosphotransferase reaction. | (pqac-00000001, pqac-00000002, pqac-00000016) |
| Pathway role | COQ8A functions in the **coenzyme Q (ubiquinone/CoQ) biosynthetic pathway** in mitochondria, helping maintain efficient de novo CoQ synthesis and broader respiratory-chain function. Loss of COQ8A impairs CoQ production and downstream oxidative phosphorylation. | (pqac-00000003, pqac-00000016, pqac-00000013) |
| Subcellular localization | Conserved ortholog data place COQ8A in the **mitochondrion**, associated with the **inner mitochondrial membrane / cristae** and CoQ-biosynthetic environment. This is the most likely localization for zebrafish coq8a as well. | (pqac-00000002, pqac-00000003, pqac-00000015) |
| Key interacting partners / complex | COQ8A associates with the **COQ metabolon / CoQ biosynthetic complex**, with reported links to **COQ3, COQ5, COQ7, and COQ9**; recent reconstitution work supports a role for COQ8 in increasing and streamlining CoQ production within the metabolon. | (pqac-00000002, pqac-00000014, pqac-00000006) |
| Organism-specific evidence in zebrafish | Direct zebrafish coq8a functional papers were not identified in the retrieved corpus. However, zebrafish studies show CoQ biology is functionally important in vivo: **tif1γ** loss reduces expression of CoQ-synthesis genes and CoQ levels, impairing erythropoiesis, and zebrafish cardiovascular studies establish developmental sensitivity to CoQ-related redox/mitochondrial defects. This supports biological relevance of zebrafish coq8a, but not a gene-specific phenotype assignment. | (pqac-00000009, pqac-00000008, pqac-00000010, pqac-00000011) |
| Recent 2023–2024 developments | Key advances include: **selective human COQ8A inhibitors** and mitochondria-targeted derivatives for chemical probing; recognition of **2-propylphenol** as a COQ8A ATPase activator; and **2024 in vitro COQ metabolon reconstruction** showing COQ8 increases/streamlines CoQ production. These sharpen the mechanistic view of COQ8A as an ATP-driven pathway regulator. | (pqac-00000012, pqac-00000016, pqac-00000014, pqac-00000004) |
| Applications / translation | Real-world uses center on **diagnosis and treatment of primary CoQ deficiency/COQ8A-ataxia**, development of **chemical probes** to dissect COQ8A function, and broader **CoQ-delivery or bypass** strategies. Reviews emphasize that early diagnosis matters because CoQ supplementation can help some patients, though bioavailability limits efficacy. | (pqac-00000013, pqac-00000016, pqac-00000017, pqac-00000015) |
| Quantitative data points | Recent quantitative examples: inhibitor discovery screened **~170,000 compounds**, selected **800** for testing, and confirmed **129 ADCK3/COQ8A inhibitors**, **114** selective vs p38 (2024). Cell assays measured reduced de novo CoQ10 at **20 µM UNC-CA157** or **17.6 µM TPP-UNC-CA157** in HAP1 models. In a zebrafish CoQ-pathway context, **58%** of plasma CoQ10 is associated with LDL (clinical biomarker caveat review). | (pqac-00000018, pqac-00000012, pqac-00000013) |


*Table: This table summarizes the best-supported functional annotation for zebrafish coq8a (UniProt Q5RGU1), integrating conserved COQ8A/ADCK3 evidence with available zebrafish CoQ-pathway studies. It is useful for quickly separating well-supported molecular functions from areas where zebrafish-specific direct evidence is still limited.*